BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 9238016)

  • 1. Receptor-associated constitutive protein tyrosine phosphatase activity controls the kinase function of JAK1.
    Haque SJ; Wu Q; Kammer W; Friedrich K; Smith JM; Kerr IM; Stark GR; Williams BR
    Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8563-8. PubMed ID: 9238016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreceptor tyrosine-based inhibitory motif of the IL-4 receptor associates with SH2-containing phosphatases and regulates IL-4-induced proliferation.
    Kashiwada M; Giallourakis CC; Pan PY; Rothman PB
    J Immunol; 2001 Dec; 167(11):6382-7. PubMed ID: 11714803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
    Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human lung myofibroblasts as effectors of the inflammatory process: the common receptor gamma chain is induced by Th2 cytokines, and CD40 ligand is induced by lipopolysaccharide, thrombin and TNF-alpha.
    Doucet C; Giron-Michel J; Canonica GW; Azzarone B
    Eur J Immunol; 2002 Sep; 32(9):2437-49. PubMed ID: 12207328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
    van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
    Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-4-induced transcriptional activation by stat6 involves multiple serine/threonine kinase pathways and serine phosphorylation of stat6.
    Pesu M; Takaluoma K; Aittomäki S; Lagerstedt A; Saksela K; Kovanen PE; Silvennoinen O
    Blood; 2000 Jan; 95(2):494-502. PubMed ID: 10627454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptors for interleukin (IL)-4 do not associate with the common gamma chain, and IL-4 induces the phosphorylation of JAK2 tyrosine kinase in human colon carcinoma cells.
    Murata T; Noguchi PD; Puri RK
    J Biol Chem; 1995 Dec; 270(51):30829-36. PubMed ID: 8530527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The IL-4 receptor alpha-chain cytoplasmic domain is sufficient for activation of JAK-1 and STAT6 and the induction of IL-4-specific gene expression.
    Reichel M; Nelson BH; Greenberg PD; Rothman PB
    J Immunol; 1997 Jun; 158(12):5860-7. PubMed ID: 9190938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-13 receptor alpha' but not alpha chain: a functional component of interleukin-4 receptors.
    Murata T; Taguchi J; Puri RK
    Blood; 1998 May; 91(10):3884-91. PubMed ID: 9573026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-13 induces phosphorylation and activation of JAK2 Janus kinase in human colon carcinoma cell lines: similarities between IL-4 and IL-13 signaling.
    Murata T; Noguchi PD; Puri RK
    J Immunol; 1996 Apr; 156(8):2972-8. PubMed ID: 8609418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
    Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
    Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9.
    Demoulin JB; Uyttenhove C; Van Roost E; DeLestré B; Donckers D; Van Snick J; Renauld JC
    Mol Cell Biol; 1996 Sep; 16(9):4710-6. PubMed ID: 8756628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-talk between interleukin 1beta (IL-1beta) and IL-6 signalling pathways: IL-1beta selectively inhibits IL-6-activated signal transducer and activator of transcription factor 1 (STAT1) by a proteasome-dependent mechanism.
    Shen X; Tian Z; Holtzman MJ; Gao B
    Biochem J; 2000 Dec; 352 Pt 3(Pt 3):913-9. PubMed ID: 11104703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-6 mediated activation of STAT3 bypasses Janus kinases in terminally differentiated B lineage cells.
    Kopantzev Y; Heller M; Swaminathan N; Rudikoff S
    Oncogene; 2002 Oct; 21(44):6791-800. PubMed ID: 12360405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4- and IL-13-dependent signal transduction.
    Haque SJ; Harbor P; Tabrizi M; Yi T; Williams BR
    J Biol Chem; 1998 Dec; 273(51):33893-6. PubMed ID: 9852037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of IL-4 and IL-13 signals dependent on the human IL-13 receptor alpha chain 1: redundancy of requirement of tyrosine residue for STAT3 activation.
    Umeshita-Suyama R; Sugimoto R; Akaiwa M; Arima K; Yu B; Wada M; Kuwano M; Nakajima K; Hamasaki N; Izuhara K
    Int Immunol; 2000 Nov; 12(11):1499-509. PubMed ID: 11058569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of IL-13- and IL-4-induced signaling in EBV-immortalized human B cells.
    Murata T; Puri RK
    Cell Immunol; 1997 Jan; 175(1):33-40. PubMed ID: 9015186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein tyrosine phosphatase activity is required for IL-4 induction of IL-4 receptor alpha-chain.
    Huang H; Paul WE
    J Immunol; 2000 Feb; 164(3):1211-5. PubMed ID: 10640732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unusual interleukin-4 and -13 signaling in human normal and tumor lung fibroblasts.
    Doucet C; Jasmin C; Azzarone B
    Oncogene; 2000 Nov; 19(51):5898-905. PubMed ID: 11127821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
    Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
    Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.